1 Mooning Stock to Own for Decades and 2 That Underwhelm
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off
3 of Wall Street’s Favorite Stocks We Approach with Caution
STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. Â (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan...
2 Reasons to Sell COLL and 1 Stock to Buy Instead
STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. Â (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global...
3 Growth Stocks We’re Skeptical Of
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS...